EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities
Dysregulation of the epigenome due to alterations in chromatin modifier proteins commonly contribute to malignant transformation. To interrogate the roles of epigenetic modifiers in cancer cells, we generated an epigenome-wide CRISPR-Cas9 knockout library (EPIKOL) that targets a wide-range of epigen...
Main Authors: | Yedier-Bayram, O, Gokbayrak, B, Kayabolen, A, Aksu, AC, Cavga, AD, Cingöz, A, Kala, EY, Karabiyik, G, Günsay, R, Esin, B, Morova, T, Uyulur, F, Syed, H, Philpott, M, Cribbs, AP, Kung, SHY, Lack, NA, Onder, TT, Bagci-Onder, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2022
|
Similar Items
-
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities
by: Ozlem Yedier-Bayram, et al.
Published: (2022-08-01) -
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival
by: Ozyerli-Goknar, E, et al.
Published: (2023) -
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
by: Saraç, H, et al.
Published: (2019) -
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming
by: Ebrahimi, A, et al.
Published: (2019) -
<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01)